Largest Ever CIDP Clinical Study Completed

Largest Ever CIDP Clinical Study Completed PATH study evaluated subcutaneous immunoglobulin efficacy and safety for treating Chronic Inflammatory Demyelinating Polyneuropathy KING OF PRUSSIA, Pa. – 01 March 2017 – Global biotherapeutics leader CSL Behring announced today that it has completed the largest ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial, known as PATH (Polyneuropathy And Treatment […]

Read More

GBS|CIDP Foundation International Named to the 2016 Classy 100

GBS|CIDP Foundation International Named to the 2016 Classy 100 Recognized as a consistent growing nonprofit on the leading online fundraising platform in 2016   Narberth, Pennsylvania –  GBS|CIDP Foundation International made this year’s Classy 100 list, an annual compilation of the growing nonprofits on Classy, the world’s leading online fundraising platform for social enterprises. Classy […]

Read More

Our Executive Director, Lisa Butler’s Interview in PPTA Winter Newsletter

PPTA Interview: Lisa Butler, Executive Director of the GBS|CIDP Foundation International BY JULIE BIRKOFER, PPTA SENIOR VICE PRESIDENT, NORTH AMERICA & GLOBAL HEALTH POLICY Can you tell me about the GBS|CIDP Foundation and the work you do? We were founded 35 years ago by Estelle Benson. Her husband, Bob Benson, was diagnosed with GBS and […]

Read More

7th Interlaken Leadership Awards

  Interlaken Leadership Awards The Interlaken Leadership Awards support original research in the field of neuroimmunology. Investigators whose proposals are approved by the review committee will receive monetary grants and/or drug supply. The size of the individual grants is not predetermined, in order to accommodate a wide variety of investigator needs. However small innovative trials […]

Read More

Regional Conference Fort Lauderdale

Brand new to our Foundation! A little spirit of a chapter meeting & a taste of a symposium – these one day conferences will bring together local physicians, members & their caregivers and loved ones.

Read More